Hippocampal Volume Changes Following Electroconvulsive Therapy: A Systematic Review and Meta-analysis

Abstract

Introduction Reduced hippocampal volume is one of the most consistent morphological findings in Major Depressive Disorder (MDD). Electroconvulsive therapy (ECT) is the most effective therapy for MDD, yet its mechanism of action remains poorly understood. Animal models show that ECT induces several neuroplastic processes, which lead to hippocampal volume increases. We conducted a meta-analysis of ECT studies in humans to investigate its effects on hippocampal volume. Methods PubMed was searched for studies examining hippocampal volume before and after ECT. A random-effects model was used for meta-analysis with standardized mean difference (SMD) of the change in hippocampal volume before and after ECT as the primary outcome. Nine studies involving 174 participants were included. Results Total hippocampal volumes increased significantly following ECT compared to pre-treatment values (SMD=1.10; 95% CI 0.80–1.39; z=7.34; p<0.001; k=9). Both right (SMD=1.01; 95% CI 0.72–1.30; z=6.76; p<0.001; k=7) and left (SMD=0.87; 95% CI 0.51–1.23; z=4.69; p<0.001; k=7) hippocampal volumes were also similarly increased significantly following ECT. We demonstrated no correlation between improvement in depression symptoms with ECT and change in total hippocampal volume (beta=−1.28, 95% CI −4.51–1.95, z=−0.78, p=0.44). Conclusion We demonstrate fairly consistent increases in hippocampal volume bilaterally following ECT treatment. The relationship among these volumetric changes and clinical improvement and cognitive side effects of ECT should be explored by larger, multisite studies with harmonized imaging methods.

Rostral anterior cingulate cortex is a structural correlate of repetitive TMS treatment response in depression

“…We hypothesized that cortical thickness would increase in the left DLPFC based on prior research showing regional structural changes at the stimulation site [3], along with increases in cortical thickness at the anterior cingulate in correspondence with clinical improvement, which may correspond to increased gray matter density reported previously [7]. In addition we measured hippocampus volume to evaluate whether nonresponders had decreased hippocampus volume with rTMS treatment, as was reported previously [5] versus hippocampal enlargement, which has been reported recently in association with rTMS treatment for depression [6] and with some consistency with electroconvulsive treatment of depression [8]. While we had specific anatomical hypotheses, our analyses included both region-of-interest (ROI) and vertex-wide analyses that were not constrained by pre-specified ROIs.…”

SMRI Biomarkers Predict Electroconvulsive Treatment Outcomes: Accuracy with Independent Data Sets

“…In contrast to the modest longitudinal GM density changes in predictive biomarkers, whole brain longitudinal analysis revealed changes in right medial temporal lobe neuroplasticity. Medial temporal lobe neuroplasticity, particularly of the hippocampus, is now a widely replicated finding in the ECT neuroimaging literature (Wilkinson et al, 2017). The treatment-responsive region had little overlap with the six predictive ROIs and more robust (order of magnitude) increase in GM density relative to longitudinal changes with the predictive ROIs.…”

Cortical thickness increases with levomilnacipran treatment in a pilot randomised double‐blind placebo‐controlled trial in late‐life depression

“…Antidepressant treatment has the ability to induce neuroplasticity similar to that observed during sensitive periods of early development . Structural neuroplastic changes have been reported in studies of different therapeutic techniques like psychotherapy, electroconvulsive and antidepressant therapies using structural MRI techniques . However, the sensorimotor system is typically not among the major reported effects.…”